Takeji Umemura

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 44

Top Venues

Hepatology research : the official journal of the Japan Society of Hepatology

PloS one

Communications medicine

Liver international : official journal of the International Association for the Study of the Liver

This page only lists publications with an associated author ORCID identifier.

Publications

Nobuharu Tamaki, Shun-Ichi Wakabayashi, Takefumi Kimura, Yutaka Yasui, Kaoru Tsuchiya, Hiroyuki Nakanishi, Daniel Q Huang, Takeji Umemura, Masayuki Kurosaki, Namiki Izumi
Glycemic control target for liver and cardiovascular events risk in metabolic dysfunction-associated steatotic liver disease. Hepatology research : the official journal of the Japan Society of Hepatology 54 (8) (2024)
Ichitaro Horiuchi, Kaori Horiuchi, Akira Horiuchi, Takeji Umemura
Serum Leucine-Rich α2 Glycoprotein Could Be a Useful Biomarker to Differentiate Patients with Normal Colonic Mucosa from Those with Inflammatory Bowel Disease or Other Forms of Colitis. Journal of clinical medicine 13 (10) (2024)
Ichitaro Horiuchi, Kaori Horiuchi, Akira Horiuchi, Takeji Umemura
Serum Leucine-Rich α2 Glycoprotein Could Be a Useful Biomarker to Differentiate Patients with Normal Colonic Mucosa from Those with Inflammatory Bowel Disease or Other Forms of Colitis. Journal of clinical medicine 13 (10) (2024)
Takanobu Iwadare, Takefumi Kimura, Taiki Okumura, Shun-Ichi Wakabayashi, Taro Nakajima, Shohei Kondo, Hiroyuki Kobayashi, Yuki Yamashita, Ayumi Sugiura, Naoyuki Fujimori, Tomoo Yamazaki, Hideo Kunimoto, Satoshi Shimamoto, Koji Igarashi, Satoru Joshita, Naoki Tanaka, Takeji Umemura
Serum autotaxin is a prognostic indicator of liver-related events in patients with non-alcoholic fatty liver disease. Communications medicine 4 (1) (2024)
Taiki Okumura, Takeji Umemura
Hepatitis B surface antigen glycan isomer as a new potential biomarker in patients with hepatitis B virus infection. Hepatology research : the official journal of the Japan Society of Hepatology (2024)
Takanobu Iwadare, Takefumi Kimura, Taiki Okumura, Shun-Ichi Wakabayashi, Taro Nakajima, Shohei Kondo, Hiroyuki Kobayashi, Yuki Yamashita, Ayumi Sugiura, Naoyuki Fujimori, Tomoo Yamazaki, Hideo Kunimoto, Satoshi Shimamoto, Koji Igarashi, Satoru Joshita, Naoki Tanaka, Takeji Umemura
Serum autotaxin is a prognostic indicator of liver-related events in patients with non-alcoholic fatty liver disease. Communications medicine 4 (1) (2024)
Takanobu Iwadare, Takefumi Kimura, Taiki Okumura, Shun-Ichi Wakabayashi, Taro Nakajima, Shohei Kondo, Hiroyuki Kobayashi, Yuki Yamashita, Ayumi Sugiura, Naoyuki Fujimori, Tomoo Yamazaki, Hideo Kunimoto, Satoshi Shimamoto, Koji Igarashi, Satoru Joshita, Naoki Tanaka, Takeji Umemura
Serum autotaxin is a prognostic indicator of liver-related events in patients with non-alcoholic fatty liver disease. Communications medicine 4 (1) (2024)
Nobuharu Tamaki, Shun-Ichi Wakabayashi, Takefumi Kimura, Yutaka Yasui, Kaoru Tsuchiya, Hiroyuki Nakanishi, Daniel Q Huang, Takeji Umemura, Masayuki Kurosaki, Namiki Izumi
Glycemic control target for liver and cardiovascular events risk in metabolic dysfunction-associated steatotic liver disease. Hepatology research : the official journal of the Japan Society of Hepatology (2024)
Ayaka Tanifuji, Satoko Ohfuji, Kosuke Matsumoto, Masanori Abe, Atsumasa Komori, Atsushi Takahashi, Kazuhito Kawata, Ken Sato, Satoru Joshita, Takeji Umemura, Masayuki Ueno, Nobuaki Nakayama, Keisuke Kakisaka, Teruko Arinaga-Hino, Koichi Ito, Sachiko Kanai, Ryo Miura, Toshihiko Arizumi, Yoshinari Asaoka, Takanori Ito, Tetsuya Shimizu, Hiroshi Yoshida, Masayuki Ohta, Suguru Mizuno, Hiroyuki Isayama, Youichi Morimoto, Satoshi Mochida, Hiromasa Ohira, Atsushi Tanaka
Safety and effectiveness of SARS-CoV-2 vaccines for patients with intractable hepatobiliary diseases: A multicenter, questionnaire-based, cross-sectional study. Hepatology research : the official journal of the Japan Society of Hepatology 54 (7) (2024)
Takanobu Iwadare, Takefumi Kimura, Taiki Okumura, Shun-Ichi Wakabayashi, Taro Nakajima, Shohei Kondo, Hiroyuki Kobayashi, Yuki Yamashita, Ayumi Sugiura, Naoyuki Fujimori, Tomoo Yamazaki, Hideo Kunimoto, Satoshi Shimamoto, Koji Igarashi, Satoru Joshita, Naoki Tanaka, Takeji Umemura
Serum autotaxin is a prognostic indicator of liver-related events in patients with non-alcoholic fatty liver disease. Communications medicine 4 (1) (2024)
Ayaka Tanifuji, Satoko Ohfuji, Kosuke Matsumoto, Masanori Abe, Atsumasa Komori, Atsushi Takahashi, Kazuhito Kawata, Ken Sato, Satoru Joshita, Takeji Umemura, Masayuki Ueno, Nobuaki Nakayama, Keisuke Kakisaka, Teruko Arinaga-Hino, Koichi Ito, Sachiko Kanai, Ryo Miura, Toshihiko Arizumi, Yoshinari Asaoka, Takanori Ito, Tetsuya Shimizu, Hiroshi Yoshida, Masayuki Ohta, Suguru Mizuno, Hiroyuki Isayama, Youichi Morimoto, Satoshi Mochida, Hiromasa Ohira, Atsushi Tanaka
Safety and effectiveness of SARS-CoV-2 vaccines for patients with intractable hepatobiliary diseases: A multicenter, questionnaire-based, cross-sectional study. Hepatology research : the official journal of the Japan Society of Hepatology 54 (7) (2024)
Ayaka Tanifuji, Satoko Ohfuji, Kosuke Matsumoto, Masanori Abe, Atsumasa Komori, Atsushi Takahashi, Kazuhito Kawata, Ken Sato, Satoru Joshita, Takeji Umemura, Masayuki Ueno, Nobuaki Nakayama, Keisuke Kakisaka, Teruko Arinaga-Hino, Koichi Ito, Sachiko Kanai, Ryo Miura, Toshihiko Arizumi, Yoshinari Asaoka, Takanori Ito, Tetsuya Shimizu, Hiroshi Yoshida, Masayuki Ohta, Suguru Mizuno, Hiroyuki Isayama, Youichi Morimoto, Satoshi Mochida, Hiromasa Ohira, Atsushi Tanaka
Safety and effectiveness of SARS-CoV-2 vaccines for patients with intractable hepatobiliary diseases: A multicenter, questionnaire-based, cross-sectional study. Hepatology research : the official journal of the Japan Society of Hepatology (2024)
Taiki Okumura, Satoru Joshita, Takanobu Iwadare, Shun-Ichi Wakabayashi, Hiroyuki Kobayashi, Yuki Yamashita, Ayumi Sugiura, Takefumi Kimura, Takeji Umemura
Kinetics of serum O-glycosylated M-hepatitis B surface antigen with hepatocellular carcinoma history and nucleos(t)ide analogue therapy in hepatitis B patients. Journal of viral hepatitis (2023)
Takeji Umemura, Kittima Wattanakamolkul, Yoshikazu Nakayama, Yasushi Takahashi, Urbano Sbarigia, Lim KyungHwa, Angelina Villasis-Keever, Martina Furegato, Laurène Gautier, Gregoire Nowacki, Jessica Azzi, David Bin-Chia Wu
Real-World Epidemiology, Clinical and Economic Burden of Chronic Hepatitis B in Japan: A Retrospective Study Using JMDC Claims Database. Infectious diseases and therapy (2023)
Taiki Okumura, Takefumi Kimura, Takanobu Iwadare, Shun-Ichi Wakabayashi, Hiroyuki Kobayashi, Yuki Yamashita, Ayumi Sugiura, Satoru Joshita, Naoyuki Fujimori, Hideo Kunimoto, Michiharu Komatsu, Hideki Fukushima, Hiromitsu Mori, Takeji Umemura
Prognostic Significance of C-Reactive Protein in Lenvatinib-Treated Unresectable Hepatocellular Carcinoma: A Multi-Institutional Study. Cancers 15 (22) (2023)
Takefumi Kimura, Takanobu Iwadare, Shun-Ichi Wakabayashi, Seema Kuldeep, Tomoyuki Nakajima, Tomoo Yamazaki, Daiki Aomura, Hamim Zafar, Mai Iwaya, Satoru Joshita, Takeshi Uehara, Sai P Pydi, Naoki Tanaka, Takeji Umemura
Thrombospondin 2 is a key determinant of fibrogenesis in non-alcoholic fatty liver disease. Liver international : official journal of the International Association for the Study of the Liver (2023)
Takanobu Iwadare, Takefumi Kimura, Hideo Kunimoto, Naoki Tanaka, Shun-Ichi Wakabayashi, Tomoo Yamazaki, Taiki Okumura, Hiroyuki Kobayashi, Yuki Yamashita, Ayumi Sugiura, Satoru Joshita, Takeji Umemura
Higher Responsiveness for Women, High Transaminase Levels, and Fat Percentage to Pemafibrate Treatment for NAFLD. Biomedicines 10 (11) (2022)
Ichitaro Horiuchi, Akira Horiuchi, Takeji Umemura
Serum Leucine-Rich α2 Glycoprotein: A Biomarker for Predicting the Presence of Ulcerative Colitis but Not Ulcerative Proctitis. Journal of clinical medicine 11 (21) (2022)
Naoyuki Fujimori, Takefumi Kimura, Naoki Tanaka, Tomoo Yamazaki, Taiki Okumura, Hiroyuki Kobayashi, Shun-Ichi Wakabayashi, Yuki Yamashita, Ayumi Sugiura, Jonathan Pham, Sai P Pydi, Kenji Sano, Satoru Joshita, Takeji Umemura
2-Step PLT16-AST44 method: Simplified liver fibrosis detection system in patients with non-alcoholic fatty liver disease. Hepatology research : the official journal of the Japan Society of Hepatology 52 (4) (2022)
Yuki Yamashita, Satoru Joshita, Ayumi Sugiura, Tomoo Yamazaki, Hiroyuki Kobayashi, Shun-Ichi Wakabayashi, Yosuke Yamada, Soichiro Shibata, Hideo Kunimoto, Takanobu Iwadare, Makiko Matsumura, Chiharu Miyabayashi, Taiki Okumura, Sachie Ozawa, Yuichi Nozawa, Natsuko Kobayashi, Michiharu Komatsu, Naoyuki Fujimori, Hiromi Saito, Takeji Umemura
aMAP score prediction of hepatocellular carcinoma occurrence and incidence-free rate after a sustained virologic response in chronic hepatitis C. Hepatology research : the official journal of the Japan Society of Hepatology 51 (9) (2021)
Takefumi Kimura, Naoki Tanaka, Naoyuki Fujimori, Tomoo Yamazaki, Takahito Katsuyama, Yuichi Iwashita, Jonathan Pham, Satoru Joshita, Sai P Pydi, Takeji Umemura
Serum thrombospondin 2 is a novel predictor for the severity in the patients with NAFLD. Liver international : official journal of the International Association for the Study of the Liver 41 (3) (2021)
Takeji Umemura, Satoru Joshita, Hiromi Saito, Shun-Ichi Wakabayashi, Hiroyuki Kobayashi, Yuki Yamashita, Ayumi Sugiura, Tomoo Yamazaki, Masao Ota
Investigation of the Effect of KIR-HLA Pairs on Hepatocellular Carcinoma in Hepatitis C Virus Cirrhotic Patients. Cancers 13 (13) (2021)
Satoru Joshita, Yuki Yamashita, Toru Okamoto, Yoko Usami, Ayumi Sugiura, Tomoo Yamazaki, Akemi Kakino, Masao Ota, Tatsuya Sawamura, Takeji Umemura
Quantitative and qualitative lipid improvement with chronic hepatitis C virus eradication using direct-acting antivirals. Hepatology research : the official journal of the Japan Society of Hepatology 51 (7) (2021)
Yuki Yamashita, Satoru Joshita, Hiroyuki Kobayashi, Shun-Ichi Wakabayashi, Ayumi Sugiura, Tomoo Yamazaki, Takeji Umemura
Primary Hepatic Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in a Patient with Chronic Hepatitis B Virus Infection: Case Report and Summary of the Literature. Medicina (Kaunas, Lithuania) 57 (3) (2021)
Shun-Ichi Wakabayashi, Satoru Joshita, Kazuhiro Kimura, Hirohiko Motoki, Hiroyuki Kobayashi, Yuki Yamashita, Ayumi Sugiura, Tomoo Yamazaki, Koichiro Kuwahara, Takeji Umemura
Protocol: Prospective observational study investigating the prevalence and clinical outcome of portopulmonary hypertension in Japanese patients with chronic liver disease. PloS one 16 (4) (2021)
Hiroyuki Kobayashi, Satoru Joshita, Yuki Akahane, Katsuhiko Matsuzaki, Hiromi Yamada, Daiki Aomura, Nao Joshita, Hajime Midorikawa, Kazuhiro Suyama, Masao Ota, Shun-Ichi Wakabayashi, Yuki Yamashita, Ayumi Sugiura, Tomoo Yamazaki, Hiromichi Misawa, Takeji Umemura
Protocol: Prospective observational study aiming for micro-elimination of hepatitis C virus in Nagawa town: The Nagawa Project. PloS one 16 (8) (2021)
Satoru Joshita, Takeji Umemura
Editorial: FAST score- a new predictive marker for HCC after SVR. Alimentary pharmacology & therapeutics 52 (7) (2020)
Minami Yagi, Kosuke Matsumoto, Atsumasa Komori, Masanori Abe, Naoaki Hashimoto, Mie Inao, Tadashi Namisaki, Kazuhito Kawata, Masashi Ninomiya, Hideki Fujii, Atsushi Takahashi, Jong-Hon Kang, Masaaki Takamura, Mie Arakawa, Satoru Joshita, Ken Sato, Jun Itakura, Takako Nomura, Keisuke Kakisaka, Akira Kaneko, Yamato Tamura, Ryo Miura, Mitsuhiko Aiso, Toshihiko Arizumi, Yoshinari Asaoka, Kentaro Kikuchi, Yasuhiro Takikawa, Tsutomu Masaki, Takeji Umemura, Akira Honda, Hiromasa Ohira, Norifumi Kawada, Hitoshi Yoshiji, Satoshi Mochida, Hajime Takikawa, Atsushi Tanaka, null null
A validation study of the Ursodeoxycholic Acid Response Score in Japanese patients with primary biliary cholangitis. Liver international : official journal of the International Association for the Study of the Liver 40 (8) (2020)
Akira Honda, Atsushi Tanaka, Tetsuji Kaneko, Atsumasa Komori, Masanori Abe, Mie Inao, Tadashi Namisaki, Naoaki Hashimoto, Kazuhito Kawata, Atsushi Takahashi, Masashi Ninomiya, Jong-Hon Kang, Mie Arakawa, Satoshi Yamagiwa, Satoru Joshita, Takeji Umemura, Ken Sato, Akira Kaneko, Kentaro Kikuchi, Jun Itakura, Takako Nomura, Keisuke Kakisaka, Hideki Fujii, Norifumi Kawada, Yasuhiro Takikawa, Tsutomu Masaki, Hiromasa Ohira, Satoshi Mochida, Hitoshi Yoshiji, Satoshi Iimuro, Yasushi Matsuzaki, Hajime Takikawa, null null
Bezafibrate Improves GLOBE and UK-PBC Scores and Long-Term Outcomes in Patients With Primary Biliary Cholangitis. Hepatology (Baltimore, Md.) 70 (6) (2019)
Satoru Joshita, Yuki Yamashita, Ayumi Sugiura, Takeshi Uehara, Yoko Usami, Tomoo Yamazaki, Naoyuki Fujimori, Akihiro Matsumoto, Eiji Tanaka, Takeji Umemura
Clinical utility of FibroScan as a non-invasive diagnostic test for primary biliary cholangitis. Journal of gastroenterology and hepatology 35 (7) (2019)
Yuki Hitomi, Kazuko Ueno, Yosuke Kawai, Nao Nishida, Kaname Kojima, Minae Kawashima, Yoshihiro Aiba, Hitomi Nakamura, Hiroshi Kouno, Hirotaka Kouno, Hajime Ohta, Kazuhiro Sugi, Toshiki Nikami, Tsutomu Yamashita, Shinji Katsushima, Toshiki Komeda, Keisuke Ario, Atsushi Naganuma, Masaaki Shimada, Noboru Hirashima, Kaname Yoshizawa, Fujio Makita, Kiyoshi Furuta, Masahiro Kikuchi, Noriaki Naeshiro, Hironao Takahashi, Yutaka Mano, Haruhiro Yamashita, Kouki Matsushita, Seiji Tsunematsu, Iwao Yabuuchi, Hideo Nishimura, Yusuke Shimada, Kazuhiko Yamauchi, Tatsuji Komatsu, Rie Sugimoto, Hironori Sakai, Eiji Mita, Masaharu Koda, Yoko Nakamura, Hiroshi Kamitsukasa, Takeaki Sato, Makoto Nakamuta, Naohiko Masaki, Hajime Takikawa, Atsushi Tanaka, Hiromasa Ohira, Mikio Zeniya, Masanori Abe, Shuichi Kaneko, Masao Honda, Kuniaki Arai, Teruko Arinaga-Hino, Etsuko Hashimoto, Makiko Taniai, Takeji Umemura, Satoru Joshita, Kazuhiko Nakao, Tatsuki Ichikawa, Hidetaka Shibata, Akinobu Takaki, Satoshi Yamagiwa, Masataka Seike, Shotaro Sakisaka, Yasuaki Takeyama, Masaru Harada, Michio Senju, Osamu Yokosuka, Tatsuo Kanda, Yoshiyuki Ueno, Hirotoshi Ebinuma, Takashi Himoto, Kazumoto Murata, Shinji Shimoda, Shinya Nagaoka, Seigo Abiru, Atsumasa Komori, Kiyoshi Migita, Masahiro Ito, Hiroshi Yatsuhashi, Yoshihiko Maehara, Shinji Uemoto, Norihiro Kokudo, Masao Nagasaki, Katsushi Tokunaga, Minoru Nakamura
POGLUT1, the putative effector gene driven by rs2293370 in primary biliary cholangitis susceptibility locus chromosome 3q13.33. Scientific reports 9 (1) (2019)
Satoru Joshita, Takeji Umemura, Yuki Yamashita, Ayumi Sugiura, Tomoo Yamazaki, Naoyuki Fujimori, Akihiro Matsumoto, Eiji Tanaka
Biochemical and plasma lipid responses to pemafibrate in patients with primary biliary cholangitis. Hepatology research : the official journal of the Japan Society of Hepatology 49 (10) (2019)
Satoru Joshita, Ayumi Sugiura, Takeji Umemura, Tomoo Yamazaki, Naoyuki Fujimori, Akihiro Matsumoto, Yoko Usami, Eiji Tanaka
Clinical impact of normal alanine aminotransferase on direct-acting antiviral outcome in patients with chronic hepatitis C virus infection. JGH open : an open access journal of gastroenterology and hepatology 4 (4) (2019)
Tomoo Yamazaki, Satoru Joshita, Takeji Umemura, Yoko Usami, Ayumi Sugiura, Naoyuki Fujimori, Takefumi Kimura, Akihiro Matsumoto, Koji Igarashi, Masao Ota, Eiji Tanaka
Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C. PloS one 13 (4) (2018)
Tomoo Yamazaki, Takeji Umemura, Satoru Joshita, Kaname Yoshizawa, Eiji Tanaka, Masao Ota
A cis-eQTL of HLA-DPB1 Affects Susceptibility to Type 1 Autoimmune Hepatitis. Scientific reports 8 (1) (2018)
Michiharu Komatsu, Naoki Tanaka, Takefumi Kimura, Naoyuki Fujimori, Kenji Sano, Akira Horiuchi, Ayumi Sugiura, Tomoo Yamazaki, Soichiro Shibata, Satoru Joshita, Takeji Umemura, Akihiro Matsumoto, Eiji Tanaka
Miglitol attenuates non-alcoholic steatohepatitis in diabetic patients. Hepatology research : the official journal of the Japan Society of Hepatology 48 (13) (2018)
Satoru Joshita, Takeji Umemura, Yoko Usami, Yuki Yamashita, Gary L Norman, Ayumi Sugiura, Tomoo Yamazaki, Naoyuki Fujimori, Takefumi Kimura, Akihiro Matsumoto, Koji Igarashi, Kaname Yoshizawa, Masao Ota, Eiji Tanaka
Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis. Scientific reports 8 (1) (2018)
Ayumi Sugiura, Satoru Joshita, Takeji Umemura, Tomoo Yamazaki, Naoyuki Fujimori, Takefumi Kimura, Akihiro Matsumoto, Koji Igarashi, Yoko Usami, Shuichi Wada, Hiromitsu Mori, Soichiro Shibata, Kaname Yoshizawa, Susumu Morita, Kiyoshi Furuta, Atsushi Kamijo, Akihiro Iijima, Satoko Kako, Atsushi Maruyama, Masakazu Kobayashi, Michiharu Komatsu, Makiko Matsumura, Chiharu Miyabayashi, Tetsuya Ichijo, Aki Takeuchi, Yuriko Koike, Yukio Gibo, Toshihisa Tsukadaira, Hiroyuki Inada, Kendo Kiyosawa, Eiji Tanaka
Past history of hepatocellular carcinoma is an independent risk factor of treatment failure in patients with chronic hepatitis C virus infection receiving direct-acting antivirals. Journal of viral hepatitis 25 (12) (2018)
Hiromi Saito, Atsuhiro Hirayama, Takeji Umemura, Satoru Joshita, Kenji Mukawa, Tomoaki Suga, Eiji Tanaka, Masao Ota
Association between KIR-HLA combination and ulcerative colitis and Crohn's disease in a Japanese population. PloS one 13 (4) (2018)
Satoru Joshita, Yuki Ichikawa, Takeji Umemura, Yoko Usami, Ayumi Sugiura, Soichiro Shibata, Tomoo Yamazaki, Naoyuki Fujimori, Michiharu Komatsu, Akihiro Matsumoto, Koji Igarashi, Masao Ota, Eiji Tanaka
Serum autotaxin is a useful liver fibrosis marker in patients with chronic hepatitis B virus infection. Hepatology research : the official journal of the Japan Society of Hepatology 48 (4) (2017)
Takeji Umemura, Satoru Joshita, Hideaki Hamano, Kaname Yoshizawa, Shigeyuki Kawa, Eiji Tanaka, Masao Ota
Association of autoimmune hepatitis with Src homology 2 adaptor protein 3 gene polymorphisms in Japanese patients. Journal of human genetics 62 (11) (2017)
Soichiro Shibata, Satoru Joshita, Takeji Umemura, Tomoo Yamazaki, Naoyuki Fujimori, Yuki Ichikawa, Michiharu Komatsu, Akihiro Matsumoto, Eiji Tanaka
Liver stiffness-spleen size-to-platelet ratio risk score detects esophageal varices in chronic liver disease. SpringerPlus 5 (1) (2016)
Takeji Umemura, Tomohiro Sekiguchi, Satoru Joshita, Tomoo Yamazaki, Naoyuki Fujimori, Soichiro Shibata, Yuki Ichikawa, Michiharu Komatsu, Akihiro Matsumoto, Zakera Shums, Gary L Norman, Eiji Tanaka, Masao Ota
Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis. Liver international : official journal of the International Association for the Study of the Liver 37 (6) (2016)
Takeji Umemura, Masao Ota
Genetic factors affect the etiology, clinical characteristics and outcome of autoimmune hepatitis. Clinical journal of gastroenterology 8 (6) (2015)

Takeji Umemura.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Takeji Umemura